On Monday, DBV Technologies SA – ADR (NASDAQ:DBVT)’s shares declined -4.74% to $25.32, as DBV Technologies Receives FDA Breakthrough Therapy Designation for Viaskin Peanut for the Treatment of Peanut Allergy in Children
DBV Technologies is the first corporation to declare Breakthrough Therapy Designation from FDA in food allergy
Breakthrough Therapy Designation was granted following positive Phase IIb trial results emphasizing the need to provide a safe pharmaceutical treatment for patients suffering from life threatening food allergies
DBV Technologies S.A. is engaged in the research, development, and marketing of products for the diagnosis and treatment of allergies, primarily food allergies in young children.
DBV declared recently that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to Viaskin(R) Peanut for children.
Breakthrough Therapy Designation is intended to expedite the development and review of drugs/biological products for serious or life-threatening diseases or conditions, such as peanut allergy. Presently, DBV is actively preparing the launch of its Phase III trial of Viaskin Peanut in Children, suffering from peanut allergy, in close coordination with the US FDA.
DBV Technologies S.A. is hold in the research, development, and marketing of products for the diagnosis and treatment of allergies, primarily food allergies in young children.
Scorpio Bulkers Inc (NYSE:SALT)’s shares dropped -4.72% to $2.02, during the last trading session on Monday, as Scorpio Bulkers, declared that its Annual Report on Form 20-F for the year ended December 31, 2014 has been filed with the Securities and Exchange Commission and can be accessed on the Corporation’s website www.scorpiobulkers.com in the Investor Relations section under Financial Reports.
Scorpio Bulkers Inc., together with its auxiliaries, engages in the marine transportation of dry bulk commodities. Its fleet transports a range of major and minor bulk commodities, counting ores, coal, grains, and fertilizers along worldwide shipping routes.
At the end of Monday’s trade, Peabody Energy Corporation (NYSE:BTU)‘s shares dipped -4.52% to $4.86, as Peabody Energy, will declare the results for the quarter ended March 31, 2015. A conference call with administration is planned for 10 a.m. CDT on Thursday, April 23.
Peabody Energy Corporation engages in the mining of coal. The corporation operates through Western U.S. Mining, Midwestern U.S. Mining, Australian Mining, Trading and Brokerage, and Corporate and Other segments. It is involved in mining and sale of thermal coal to electric utilities and metallurgical coal for industrial customers.
Cheetah Mobile Inc (ADR) (NYSE:CMCM), ended its Monday’s trading session with -4.44% loss, and closed at $22.62, as Cheetah Mobile, declared a commercial contract with Nanigans, a global provider of social and mobile advertising software and pioneer in advertising automation software.
The commercial contract comes in conjunction with Cheetah Mobile’s recent investment as the lead investor in Nanigans $24 million Series B financing.
Under the terms of the contract, Cheetah Mobile will be the exclusive partner of Nanigans in the Greater China region to manage campaigns for advertisers by using Nanigans’ advertising automation software.
Cheetah Mobile Inc. operates a platform that offer mission critical applications for its users and global content distribution channels for its business partners in the People’s Republic of China.
DISCLAIMER:
This article is published by www.wsnewspublishers.com. The Content included in this article is just for informational purposes only. All information used in this article is believed to be from reliable sources, but we make no representations or warranties of any kind, express or implied, about the completeness, accuracy, or reliability with respect to this article.
All visitors are advised to conduct their own independent research into individual stocks before making a purchase decision.
Information contained in this article contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, counting statements regarding the predictable continual growth of the market for the corporation’s products, the corporation’s ability to fund its capital requirement in the near term and in the long term; pricing pressures; etc.
Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, aims, assumptions, or future events or performance may be forward looking statements. Forward-looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements may be identified through the use of such words as expects, will, anticipates, estimates, believes, or by statements indicating certain actions may, could, should might occur.
